Adjunctive Use of Fute (Flupentixol) in Multi-acting Receptor-targeted Antipsychotics Treated Schizophrenia Patients
Conditions: Schizophrenia; Psychosis; Metabolic Syndrome; Flupentixol; Antipsychotic Agents; Central Nervous System Diseases; Clinical Therapy; Olanzapine; Quetiapine Interventions: Drug: Flupentixol; Drug: Multi-acting receptor-targeted antipsychotics (MARTAs) Sponsor: Taichung Veterans General Hospital Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 24, 2021 Category: Research Source Type: clinical trials